HealthTIES Consortium has been created to promote innovation in healthcare technology and is backed by the European Union. Four top European regions in biosciences, med-tech and health entrepreneurship join forces in HealthTIES project: Medical Delta, Biocat, Life Sciences Zurich and Oxford and Thames Valley. A fifth region, to be mentored by the other partners, is Ëszak-Alföld.
HealthTIES has an innovative way of working: as from the identification of four major disease areas (cardiovascular, cancer, neurodegenerative and immunology and infectious diseases) and three technology platforms (molecular technology, imaging and drug design), the work is focused in the different interactions between them.
One of the main concerns is to speed up the transfer from science to market or, in other words, from idea to product. And, in this sense, we foster the connections between the Triple Helix: academia, industry and government.
HealthTIES, making the European Union a world-class player in healthcare technology!
News
Published 12 April 2012 - Researchers at ETH Zurich and the University of Zurich identify a new method of unerringly detecting the presence of pathophysiological changes in the brain.
Published 4 April 2012 - Cytosurge AG, Zurich was awarded for the groundbreaking and pioneering market introduction of the FluidFM® technology.
Published 3 April 2012 - The Swiss biotech industry can look back on a surprisingly good year despite of the strength of the Swiss franc and the economic weakness. The Biotech Report 2012 shows significant investment in the sector.
No front page content has been created yet.
